Physical Activity in Patients With Rheumatoid Arthritis Treated With Adalimumab in Routine Clinical Practice
Phase of Trial: Phase IV
Latest Information Update: 17 Jun 2017
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms PACE
- Sponsors Abbott Laboratories; AbbVie
- 17 Jun 2017 Results assessing effect of adalimumab treatment on physical activity and relationship with improvements in disease activity presented at the 18th Annual Congress of the European League Against Rheumatism.
- 20 Nov 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 17 Feb 2015 Planned number of patients changed from 550 to 1000 as reported by ClinicalTrials.gov record.